Search
for

    Sort by

    Research 30 of 108

    1. Séquelles cutanéomuqueuses et oculaires des SJS et de Lyell Annales de Dermatologie et de Vénéréologie · 2010 · 13 citations
    2. Toxic Epidermal Necrolysis Medical Clinics of North America · 1980 · 74 citations
    3. Sarcoïdose grave Revue des Maladies Respiratoires · 2014
    4. Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome 2003 · 192 citations
    5. Polycystic ovary syndrome The Lancet · 2007 · 989 citations
    6. Obesity and the Polycystic Ovary Syndrome Medical Clinics of North America · 2007 · 28 citations
    7. Actualización del Síndrome de Ovario Poliquístico y su importancia en Dermatología Revista Chilena de Dermatología · 2015
    8. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up British Journal of Dermatology · 2017 · 105 citations
    9. Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Drug Safety · 2017 · 33 citations
    10. Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome Hypertension · 2007 · 166 citations
    11. The effect of metformin on hirsutism in polycystic ovary syndrome European journal of endocrinology · 2002 · 90 citations
    12. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial Gynecological Endocrinology · 2010 · 60 citations
    13. Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome European journal of endocrinology · 2008 · 56 citations
    14. Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome European Journal of Endocrinology · 2011 · 50 citations
    15. Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference? Nutrition in Clinical Practice · 2008 · 48 citations
    16. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. European journal of endocrinology · 2008 · 40 citations
    17. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Human Reproduction · 2004 · 38 citations
    18. Polycystic ovary syndrome: A review for dermatologists Journal of The American Academy of Dermatology · 2014 · 30 citations
    19. Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome Dermatology · 2008 · 17 citations
    20. Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome Journal of the Formosan Medical Association · 2016 · 6 citations
    21. Treatment of hyperandrogenism in polycystic ovary syndrome Cambridge University Press eBooks · 2010 · 1 citations
    22. Exploring the therapeutic potential of metformin in polycystic ovary syndrome: focusing on hyperandrogenism in a sample of Iraqi women Reproductive health of woman · 2025
    23. The Association of Polycystic Ovarian Syndrome Among Reproductive-Aged Women With Consumption of Junk Food in Jeddah, Saudi Arabia Curēus · 2023
    24. Polycystic Ovarian Syndrome and Obstructive Sleep Apnea Current Respiratory Medicine Reviews · 2007
    25. Pharmacotherapy of polycystic ovary syndrome - an update Fundamental & Clinical Pharmacology · 2011 · 34 citations
    26. Therapeutic options in the polycystic ovary syndrome Journal of Obstetrics and Gynaecology · 2007 · 16 citations
    27. NEW PROPRIETARY BRANDS: Gabapentin Australian Prescriber · 2004
    28. NEW PROPRIETARY BRANDS: Cephalexin Australian Prescriber · 2004
    29. NEW FORMULATIONS: Sodium cromoglycate Australian Prescriber · 2004
    30. NEW PROPRIETARY BRANDS: Cefaclor monohydrate Australian Prescriber · 2004